NCT01915147View on ClinicalTrials.gov

A Study to Explore the Influence of Two Opioid Pain Medications on Bacterial Composition in the Gut and Other Gastrointestinal Aspects

PHASE2CompletedINTERVENTIONAL
Enrollment

108

Participants

Timeline

Start Date

July 31, 2013

Primary Completion Date

February 28, 2015

Study Completion Date

September 30, 2015

Conditions
Severe Chronic Pain
Interventions
DRUG

OXN PR followed by OxyPR tablets

DRUG

OxyPR followed by OXN PR tablets

Trial Locations (2)

35578

Dr J Hafer, Wetzlar

55116

Gemeinschaftspraxis Loewenstein, Mainz

All Listed Sponsors
lead

Mundipharma Research GmbH & Co KG

INDUSTRY

NCT01915147 - A Study to Explore the Influence of Two Opioid Pain Medications on Bacterial Composition in the Gut and Other Gastrointestinal Aspects | Biotech Hunter | Biotech Hunter